SurgSpace / Specialties / Urology
Urology
Kidneys, ureters, bladder, prostate and the male reproductive tract: stones and the obstructed infected kidney that cannot wait, bladder cancer surveyed and resected through the urethra, and a specialty that reached keyhole surgery before almost anyone else.
See the disease
Conditions
The diseases, each with the image that defines it.
Each disease with the image that defines it: what it looks like, what the scan shows, and which operation answers it.
Urinary stone disease
Crystals, colic, and the one presentation that cannot wait.
- The disease
- Supersaturated urine crystallises, most often as calcium oxalate: dehydration, diet, anatomy and metabolic factors load the dice, and a first stone predicts more.
- Colic
- A stone entering the ureter announces itself in waves of loin-to-groin pain with a patient who cannot lie still: non-contrast CT is the diagnostic standard, and NSAIDs are the analgesic of choice where kidneys allow.
- Who passes and who does not
- Small distal stones mostly pass with time and analgesia; larger and more proximal stones increasingly do not, and persistent obstruction, uncontrolled pain or a solitary kidney move treatment forward.
Learn more
- The toolbox
- Shockwave lithotripsy from outside, ureteroscopy and laser from inside, percutaneous surgery for the big renal burdens: choice follows stone size, site and hardness.
- The emergency
- Fever plus obstructing stone equals urgent decompression, stent or nephrostomy, with stone treatment deferred: the one rule in this condition that is never negotiated.

Bladder cancer
A field disease of the urothelium, staged by one muscle layer.
- Presentation
- Painless visible haematuria is the classic herald; persistent non-visible haematuria and refractory 'UTIs' in smokers are the quieter ones.
- The staging fork
- Everything divides at the detrusor: non-muscle-invasive disease is resected endoscopically and surveilled, sometimes for decades; muscle-invasive disease is a different cancer needing radical treatment.
- TURBT's double job
- The resection treats and stages at once, which is why sampling muscle in the specimen is a quality criterion: a TURBT without muscle may need doing again.
Learn more
- The long relationship
- Non-muscle-invasive disease recurs habitually: surveillance cystoscopy, intravesical BCG or chemotherapy, and re-resection make bladder cancer one of oncology's longest doctor-patient relationships.
Benign prostatic obstruction
The ageing prostate, the frustrated bladder, and the flow between them.
- Mechanism
- Benign hyperplasia narrows the prostatic urethra; the detrusor first compensates with muscle, then fails with residuals: symptoms come from both the blockage and the bladder's response to it.
- Assessment
- Symptom scores, flow rate and residual volume quantify what the history sketches; examination and PSA keep the cancer question honestly in view.
- Management ladder
- Lifestyle and fluid timing, alpha-blockers for tone, 5-alpha-reductase inhibitors for bulk, and surgery, TURP as the reference operation, for retention, failed medication or complications.
Learn more
- Complications of neglect
- Recurrent infection, bladder stones, high-pressure chronic retention and renal impairment: the end-stage bladder is the argument for not ignoring years of nocturia.
Prostate cancer
A common cancer with an uncommon spread of tempos.
- The spectrum
- From indolent low-grade disease many men die with rather than of, to aggressive disease that metastasises to bone: grade (Gleason patterns) and stage set which story this is.
- Diagnosis
- PSA opens the question, multiparametric MRI shapes it, targeted biopsy answers it: the modern sequence reduces both missed cancers and unnecessary needles.
- Management by tempo
- Active surveillance monitors low-risk disease with intent to treat only on progression; surgery and radiotherapy treat localised significant disease; hormonal and systemic therapy manage the advanced.
Learn more
- The honest trade
- Continence and potency are the currencies every radical treatment spends: shared decision-making is not a courtesy here, it is the clinical method.
Hub shaped by the Surgical Specialties Lead with the Urology reviewer (open seat). Images and videos carry their source; educational use for supervised learning, not clinical guidance.